ABELMOSCHUS
ABELMOSCHUS is an FDA drug label for the active ingredient ABELMOSCHUS MOSCHATUS SEED manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231013.
Generic: ABELMOSCHUS MOSCHATUS SEED
Manufacturer: Boiron
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 0220-0003
Application:
Effective: 20231013
Active Ingredients: Active ingredient**: See product name on front panel Abelmoschus 200CK (**contains 0.443 mg of the active ingredient per pellet)
Indications & Usage
Relieves sleepiness with excess salivation *
Dosage & Administration
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.
More from same ingredient
No related products.